BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $421,311 | -17.6% | 11,223 | 0.0% | 0.10% | -14.4% |
Q2 2023 | $511,320 | +12.3% | 11,223 | 0.0% | 0.11% | -0.9% |
Q1 2023 | $455,205 | +50.8% | 11,223 | +89.5% | 0.11% | +34.9% |
Q4 2022 | $301,895 | -6.8% | 5,923 | 0.0% | 0.08% | -8.8% |
Q3 2022 | $324,000 | -14.7% | 5,923 | 0.0% | 0.09% | -13.3% |
Q2 2022 | $380,000 | -17.2% | 5,923 | 0.0% | 0.10% | 0.0% |
Q1 2022 | $459,000 | -11.9% | 5,923 | 0.0% | 0.10% | -13.9% |
Q4 2021 | $521,000 | -45.3% | 5,923 | -50.0% | 0.12% | +19.6% |
Q3 2021 | $952,000 | +100.0% | 11,846 | +100.0% | 0.10% | -23.9% |
Q2 2021 | $476,000 | -4.6% | 5,923 | 0.0% | 0.13% | -15.7% |
Q1 2021 | $499,000 | +5.1% | 5,923 | 0.0% | 0.16% | -9.1% |
Q4 2020 | $475,000 | -0.2% | 5,923 | 0.0% | 0.18% | -12.9% |
Q3 2020 | $476,000 | -6.7% | 5,923 | 0.0% | 0.20% | -19.0% |
Q2 2020 | $510,000 | +6.0% | 5,923 | 0.0% | 0.25% | -24.2% |
Q1 2020 | $481,000 | -28.3% | 5,923 | -22.7% | 0.33% | -19.7% |
Q3 2019 | $671,000 | +85.9% | 7,666 | +73.7% | 0.41% | +69.6% |
Q2 2019 | $361,000 | +0.6% | 4,413 | 0.0% | 0.24% | +66.7% |
Q1 2019 | $359,000 | -7.7% | 4,413 | -25.4% | 0.14% | -50.0% |
Q4 2018 | $389,000 | +2.4% | 5,913 | -0.7% | 0.29% | +16.6% |
Q3 2018 | $380,000 | -13.0% | 5,956 | +0.7% | 0.25% | -22.8% |
Q2 2018 | $437,000 | +13.5% | 5,913 | 0.0% | 0.32% | +9.6% |
Q1 2018 | $385,000 | +0.8% | 5,913 | 0.0% | 0.29% | -9.6% |
Q4 2017 | $382,000 | -48.5% | 5,913 | -50.0% | 0.32% | -0.3% |
Q3 2017 | $742,000 | +107.3% | 11,826 | +100.0% | 0.32% | -18.0% |
Q2 2017 | $358,000 | – | 5,913 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |